Separation of Antagonists
Separation of Antagonists
Separation of Antagonists
Separation of Antagonists
Separation of Antagonists
- Application Number
- 123560
- Method
- HPLC
- Results
.gif)
Legend:
1 - famotidine 2 - cimetidine 3 - nizatidine 4 - pirenzepine dihydrochloride- Substances
- famotidine; cimetidine; nizatidine; pirenzepine dihydrochloride
- Product(s)
Phase REF Webshop NUCLEODUR C18 HTec
760312.46
- Matrix
- Sample(s)
Concentrations in methanol famotidine: 2 mg/mL cimetidine: 2 mg/mL nizatidine: 5 mg/mL pirenzepine dihydrochloride: 5 mg/mL
- Conditions
Eluent: methanol / 20 mM KH2PO4, adjusted with TEA to pH 7 (20:80, v/v) Flow rate: 1.3 mL/min Temperature: 25 °C Injection volume: 15.0 µL
- Detection
- UV, 254 nm
- Note
- Author
- HPLC department
- Source
- MACHEREY-NAGEL, Germany 2010
- Disclaimer
- Concerning questions to literature applications please contact the cited author/s. Chemicals mentioned in applications are not manufactured or sold by MACHEREY-NAGEL. Applications mentioned in MACHEREY-NAGEL literature or databases are provided for informational purposes only. MACHEREY-NAGEL does not warrant that all applications have been tested in MACHEREY-NAGEL laboratories using MACHEREY-NAGEL products. MACHEREY-NAGEL does not warrant the correctness of the applications.
- Dateien
- Lädt...